Hypertension Treatment in Nigeria: Hypertension Diabetes Integration Study- Formative Aim 3
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2800 participants.
Also called NCT07589387
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose health services research
- Phase
- Not applicable
- Enrolled
- 2,800 participants
- Registry
-
NCT07589387
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Nigeria
- Registry status
- Recruiting
Technical summary
Registry record NCT07589387. Allocation not applicable; no masking; primary purpose health services research. Start 2026-02-14 (actual); primary completion 2029-04-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Hypertension Treatment in Nigeria: Hypertension Diabetes Integration Study- Formative Aim 3
- Acronym
- HTN2
- Condition
- Diabete Mellitus
- Intervention (Other)
- Implementation of program based on WHO HEARTS-D guidelines
- Intervention (Drug)
- Metformin
- Intervention (Drug)
- Glimepiride
- Intervention (Device)
- Point-of-care blood glucose monitor (glucometer) and compatible test strips
- Intervention (Behavioral)
- HEARTS-D training and quarterly supportive supervision for community health extension workers (CHEWs)
- Lead sponsor
- Washington University School of Medicine
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator
- University of Abuja Teaching Hospital
Record details
- Record id
cardio:ct-nct07589387- Content hash
72f9ab5609814d64b1cebe362eff3418b853c085f3b620c51fc0e1ec0ec444e5